883 related articles for article (PubMed ID: 32319703)
1. Role of Microbiome and Antibiotics in Autoimmune Diseases.
Vangoitsenhoven R; Cresci GAM
Nutr Clin Pract; 2020 Jun; 35(3):406-416. PubMed ID: 32319703
[TBL] [Abstract][Full Text] [Related]
2. The role of the gut microbiome in systemic inflammatory disease.
Clemente JC; Manasson J; Scher JU
BMJ; 2018 Jan; 360():j5145. PubMed ID: 29311119
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota and inflammatory bowel disease: so far so gut!
Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
[TBL] [Abstract][Full Text] [Related]
4. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.
Oka A; Sartor RB
Dig Dis Sci; 2020 Mar; 65(3):757-788. PubMed ID: 32006212
[TBL] [Abstract][Full Text] [Related]
5. Microbial modulation of the gut microbiome for treating autoimmune diseases.
Balakrishnan B; Taneja V
Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):985-996. PubMed ID: 30146910
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
Qiao YQ; Cai CW; Ran ZH
J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
Lee M; Chang EB
Gastroenterology; 2021 Jan; 160(2):524-537. PubMed ID: 33253681
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota in autoimmunity: potential for clinical applications.
Kim D; Yoo SA; Kim WU
Arch Pharm Res; 2016 Nov; 39(11):1565-1576. PubMed ID: 27444041
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.
Fong W; Li Q; Yu J
Oncogene; 2020 Jun; 39(26):4925-4943. PubMed ID: 32514151
[TBL] [Abstract][Full Text] [Related]
10. Intestinal dysbiosis and probiotic applications in autoimmune diseases.
de Oliveira GLV; Leite AZ; Higuchi BS; Gonzaga MI; Mariano VS
Immunology; 2017 Sep; 152(1):1-12. PubMed ID: 28556916
[TBL] [Abstract][Full Text] [Related]
11. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.
Schulberg J; De Cruz P
Intern Med J; 2016 Mar; 46(3):266-73. PubMed ID: 26968595
[TBL] [Abstract][Full Text] [Related]
12. Targeting gut microbiota as a possible therapy for diabetes.
He C; Shan Y; Song W
Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
[TBL] [Abstract][Full Text] [Related]
13. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
[TBL] [Abstract][Full Text] [Related]
14. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
Vemuri RC; Gundamaraju R; Shinde T; Eri R
Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
[TBL] [Abstract][Full Text] [Related]
16. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.
Mishima Y; Sartor RB
J Gastroenterol; 2020 Jan; 55(1):4-14. PubMed ID: 31482438
[TBL] [Abstract][Full Text] [Related]
17. Probiotics, prebiotics and amelioration of diseases.
Tsai YL; Lin TL; Chang CJ; Wu TR; Lai WF; Lu CC; Lai HC
J Biomed Sci; 2019 Jan; 26(1):3. PubMed ID: 30609922
[TBL] [Abstract][Full Text] [Related]
18. Leveraging diet to engineer the gut microbiome.
Wolter M; Grant ET; Boudaud M; Steimle A; Pereira GV; Martens EC; Desai MS
Nat Rev Gastroenterol Hepatol; 2021 Dec; 18(12):885-902. PubMed ID: 34580480
[TBL] [Abstract][Full Text] [Related]
19. Restoration of dysbiotic human gut microbiome for homeostasis.
Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
[TBL] [Abstract][Full Text] [Related]
20. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.
Gallo A; Passaro G; Gasbarrini A; Landolfi R; Montalto M
World J Gastroenterol; 2016 Aug; 22(32):7186-202. PubMed ID: 27621567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
